Richard Spector
Corporate Officer/Principal bij FEMASYS INC.
Vermogen: - $ op 31-05-2024
Actieve functies van Richard Spector
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| FEMASYS INC. | Corporate Officer/Principal | 01-02-2024 | - |
Loopbaan van Richard Spector
Eerdere bekende functies van Richard Spector
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INSULET CORPORATION | Corporate Officer/Principal | - | - |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Verkoop & Marketing | - | - |
QLibrium, Inc.
 QLibrium, Inc. Medical DistributorsDistribution Services QLibrium, Inc. distributes on-body drug delivery systems. The private company is located in the US. | Corporate Officer/Principal | - | - |
Opleiding van Richard Spector
| The California State University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Sales & Marketing | 1 |
Sectoraal
| Health Technology | 3 |
| Electronic Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| FEMASYS INC. | Electronic Technology |
| INSULET CORPORATION | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
QLibrium, Inc.
QLibrium, Inc. Medical DistributorsDistribution Services QLibrium, Inc. distributes on-body drug delivery systems. The private company is located in the US. | Distribution Services |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
- Beurs
- Insiders
- Richard Spector
- Ervaring
